Skip to main content
Top
Published in: Inflammation 5/2014

01-10-2014

The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?

Authors: Tuğçe Demirtaş, Tijen Utkan, Ayşe Karson, Yusufhan Yazır, Dilek Bayramgürler, Nejat Gacar

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

Inflammation has been suggested to be associated with stress-induced depression and cardiovascular dysfunction. Tumor necrosis factor alpha (TNF-α) is a major cytokine in the activation of neuroendocrine, immune, and behavioral responses. In this study, we investigated the effects of infliximab (a TNF-α inhibitor) on endothelium-dependent vascular reactivity, systemic blood pressure, and endothelial nitric oxide synthase (eNOS) immunoreactivity in the unpredictable chronic mild stress (UCMS) model of depression in rats. There was no significant change between all groups in the systemic blood pressure. In UCMS, endothelium-dependent relaxation of the smooth muscle in response to carbachol was significantly decreased with 50 % maximal response (E max) and pD2 values compared with the controls. Infliximab was able to reverse this UCMS effect. Relaxation in response to the nitric oxide (NO) donor sodium nitroprusside and papaverine and KCl-induced contractile responses was similar between groups. In UCMS, decreased expression of eNOS was detected. Moreover, there was no significant change in UCMS + infliximab group with respect to control rats. Our results suggest that tumor necrosis factor-alpha (TNF-α) could be a major mediator of vascular dysfunction associated with UCMS, leading to decreased expression of eNOS.
Literature
1.
go back to reference Black, P.H., and L.D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52: 1–23.PubMedCrossRef Black, P.H., and L.D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52: 1–23.PubMedCrossRef
2.
go back to reference Strike, P.C., and A. Steptoe. 2004. Psychosocial factors in the development of coronary artery disease. Progress in Cardiovascular Diseases 46: 337–347.PubMedCrossRef Strike, P.C., and A. Steptoe. 2004. Psychosocial factors in the development of coronary artery disease. Progress in Cardiovascular Diseases 46: 337–347.PubMedCrossRef
3.
go back to reference Naldi, L., and S.R. Mercuri. 2010. Epidemiology of comorbidities in psoriasis. Dermatologic Therapy 23: 114–118. Review.PubMedCrossRef Naldi, L., and S.R. Mercuri. 2010. Epidemiology of comorbidities in psoriasis. Dermatologic Therapy 23: 114–118. Review.PubMedCrossRef
4.
go back to reference Michaud, K., and F. Wolfe. 2007. Comorbidities in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 21: 885–906. Review.CrossRef Michaud, K., and F. Wolfe. 2007. Comorbidities in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 21: 885–906. Review.CrossRef
5.
go back to reference Mosovich, S.A., R.T. Boone, A. Reichenberg, S. Bansilal, J. Shaffer, K. Dahlman, P.D. Harvey, and M.E. Farkouh. 2008. New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice 62: 423–432. Review.PubMedCrossRef Mosovich, S.A., R.T. Boone, A. Reichenberg, S. Bansilal, J. Shaffer, K. Dahlman, P.D. Harvey, and M.E. Farkouh. 2008. New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice 62: 423–432. Review.PubMedCrossRef
6.
go back to reference Lett, H.S., J. Davidson, and J.A. Blumenthal. 2005. Nonpharmacologic treatments for depression in patients with coronary heart disease. Psychosomatic Medicine 67(Suppl 1): S58–S62.PubMedCrossRef Lett, H.S., J. Davidson, and J.A. Blumenthal. 2005. Nonpharmacologic treatments for depression in patients with coronary heart disease. Psychosomatic Medicine 67(Suppl 1): S58–S62.PubMedCrossRef
7.
go back to reference Plante, G.E. 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism, Clinical and Experimental 54: 45–48. Review.CrossRef Plante, G.E. 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism, Clinical and Experimental 54: 45–48. Review.CrossRef
8.
go back to reference Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef
9.
go back to reference Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctôt. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctôt. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef
10.
go back to reference Pollak, Y., and R. Yirmiya. 2002. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology 5: 389–399.PubMedCrossRef Pollak, Y., and R. Yirmiya. 2002. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology 5: 389–399.PubMedCrossRef
11.
go back to reference Capuron, L., and A.H. Miller. 2004. Cytokines and psychopathology: lessons from interferon-alpha. Biological Psychiatry 56: 819–824.PubMedCrossRef Capuron, L., and A.H. Miller. 2004. Cytokines and psychopathology: lessons from interferon-alpha. Biological Psychiatry 56: 819–824.PubMedCrossRef
12.
go back to reference Willner, P., R. Muscat, and M. Papp. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 16: 525–534. Review.PubMedCrossRef Willner, P., R. Muscat, and M. Papp. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 16: 525–534. Review.PubMedCrossRef
13.
go back to reference Willner, P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.PubMedCrossRef Willner, P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.PubMedCrossRef
14.
go back to reference Willner, P. 2005. Chronic mild stress (CMS) revisited: consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110. Review.PubMedCrossRef Willner, P. 2005. Chronic mild stress (CMS) revisited: consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110. Review.PubMedCrossRef
15.
go back to reference Karson, A., T. Demirtas, D. Bayramgürler, F. Balcı, and T. Utkan. 2013. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic & Clinical Pharmacology & Toxicology 112(5): 335–340.CrossRef Karson, A., T. Demirtas, D. Bayramgürler, F. Balcı, and T. Utkan. 2013. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic & Clinical Pharmacology & Toxicology 112(5): 335–340.CrossRef
16.
go back to reference Yazir, Y., T. Utkan, and F. Aricioglu. 2012. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology 111(3): 154–160. Yazir, Y., T. Utkan, and F. Aricioglu. 2012. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology 111(3): 154–160.
17.
go back to reference Bayramgurler, D., A. Karson, Y. Yazir, I.K. Celikyurt, S. Kurnaz, and T. Utkan. 2013. The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats. European Journal of Pharmacology 710(1–3): 67–72.PubMedCrossRef Bayramgurler, D., A. Karson, Y. Yazir, I.K. Celikyurt, S. Kurnaz, and T. Utkan. 2013. The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats. European Journal of Pharmacology 710(1–3): 67–72.PubMedCrossRef
18.
go back to reference Behrendt, D., and P. Ganz. 2002. Endothelial function. From vascular biology to clinical applications. The American Journal of Cardiology 90: 40–48.CrossRef Behrendt, D., and P. Ganz. 2002. Endothelial function. From vascular biology to clinical applications. The American Journal of Cardiology 90: 40–48.CrossRef
19.
go back to reference Broadly, A.J., A. Korszun, C.J. Jones, and M.P. Frenneaux. 2002. Arterial endothelial function is impaired in treated depression. Heart 88(5): 521–523.CrossRef Broadly, A.J., A. Korszun, C.J. Jones, and M.P. Frenneaux. 2002. Arterial endothelial function is impaired in treated depression. Heart 88(5): 521–523.CrossRef
20.
go back to reference Rybakowski, J.K., A. Wykretowicz, A. Heymann-Szlachcinska, and H. Wysocki. 2006. Impairment of endothelial function in unipolar and bipolar depression. Biological Psychiatry 60(8): 889–891.PubMedCrossRef Rybakowski, J.K., A. Wykretowicz, A. Heymann-Szlachcinska, and H. Wysocki. 2006. Impairment of endothelial function in unipolar and bipolar depression. Biological Psychiatry 60(8): 889–891.PubMedCrossRef
21.
go back to reference Le Mellédo, J.M., N. Mahil, and G.B. Baker. 2004. Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry & Neuroscience 29: 414–416. Le Mellédo, J.M., N. Mahil, and G.B. Baker. 2004. Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry & Neuroscience 29: 414–416.
22.
go back to reference Chrapko, W.E., P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biological Psychiatry 15: 129–134.CrossRef Chrapko, W.E., P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biological Psychiatry 15: 129–134.CrossRef
23.
go back to reference d’Audiffret, A.C., S.J. Frisbee, P.A. Stapleton, A.G. Goodwill, E. Isingrini, and J.C. Frisbee. 2010. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? Journal of Applied Physiology 108: 1041–1051.PubMedCrossRefPubMedCentral d’Audiffret, A.C., S.J. Frisbee, P.A. Stapleton, A.G. Goodwill, E. Isingrini, and J.C. Frisbee. 2010. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? Journal of Applied Physiology 108: 1041–1051.PubMedCrossRefPubMedCentral
24.
go back to reference Isingrini, E., A. Surget, C. Belzung, J.L. Freslon, J. Frisbee, J. O’Donnell, V. Camus, and A. d’Audiffret. 2011. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiology & Behavior 103: 540–546.CrossRef Isingrini, E., A. Surget, C. Belzung, J.L. Freslon, J. Frisbee, J. O’Donnell, V. Camus, and A. d’Audiffret. 2011. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiology & Behavior 103: 540–546.CrossRef
25.
go back to reference Isingrini, E., C. Belzung, J.L. Freslon, M.C. Machet, and V. Camus. 2012. Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosomatic Medicine 74: 63–72.PubMedCrossRef Isingrini, E., C. Belzung, J.L. Freslon, M.C. Machet, and V. Camus. 2012. Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosomatic Medicine 74: 63–72.PubMedCrossRef
26.
go back to reference Nieuwdorp, M., M.C. Meuwese, H.L. Mooij, M.H. van Lieshout, A. Hayden, M. Levi, J.C. Meijers, C. Ince, J.J. Kastelein, H. Vink, and E.S. Stroes. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202(1): 296–303.PubMedCrossRef Nieuwdorp, M., M.C. Meuwese, H.L. Mooij, M.H. van Lieshout, A. Hayden, M. Levi, J.C. Meijers, C. Ince, J.J. Kastelein, H. Vink, and E.S. Stroes. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202(1): 296–303.PubMedCrossRef
27.
go back to reference Arenas, I.A., Y. Xu, P. Lopez-Jaramillo, and S.T. Davidge. 2004. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. American Journal of Physiology. Cell Physiology 286: 779–784.CrossRef Arenas, I.A., Y. Xu, P. Lopez-Jaramillo, and S.T. Davidge. 2004. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. American Journal of Physiology. Cell Physiology 286: 779–784.CrossRef
28.
go back to reference Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef
29.
go back to reference Lu, X.T., Y.F. Liu, L. Zhang, R.X. Yang, X.Q. Liu, F.F. Yan, Y.B. Wang, W.W. Bai, Y.X. Zhao, and F. Jiang. 2012. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosomatic Medicine 74: 604–611.PubMedCrossRef Lu, X.T., Y.F. Liu, L. Zhang, R.X. Yang, X.Q. Liu, F.F. Yan, Y.B. Wang, W.W. Bai, Y.X. Zhao, and F. Jiang. 2012. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosomatic Medicine 74: 604–611.PubMedCrossRef
30.
go back to reference Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789): 373–376.PubMedCrossRef Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789): 373–376.PubMedCrossRef
31.
go back to reference Ignarro, L.J., K.S. Wood, and M.S. Wolin. 1982. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proceedings of the National Academy of Sciences of the United States of America 79: 2870–2873.PubMedCrossRefPubMedCentral Ignarro, L.J., K.S. Wood, and M.S. Wolin. 1982. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proceedings of the National Academy of Sciences of the United States of America 79: 2870–2873.PubMedCrossRefPubMedCentral
32.
go back to reference Grippo, A.J., J. Francis, T.G. Beltz, R.B. Felder, and A.K. Johnson. 2005. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology & Behavior 84: 697–706.CrossRef Grippo, A.J., J. Francis, T.G. Beltz, R.B. Felder, and A.K. Johnson. 2005. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology & Behavior 84: 697–706.CrossRef
33.
go back to reference Csiszar, A., N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari. 2007. Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. The American Journal of Pathology 170: 388–398.PubMedCrossRefPubMedCentral Csiszar, A., N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari. 2007. Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. The American Journal of Pathology 170: 388–398.PubMedCrossRefPubMedCentral
34.
go back to reference Hürlimann, D., A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, and F. Ruschitzka. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184–2187.PubMedCrossRef Hürlimann, D., A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, and F. Ruschitzka. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184–2187.PubMedCrossRef
35.
go back to reference Fichtlscherer, S., L. Rössig, S. Breuer, M. Vasa, S. Dimmeler, and A.M. Zeiher. 2001. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 18: 3023–3025.CrossRef Fichtlscherer, S., L. Rössig, S. Breuer, M. Vasa, S. Dimmeler, and A.M. Zeiher. 2001. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 18: 3023–3025.CrossRef
36.
go back to reference Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef
37.
go back to reference Murphy, H.S., J.A. Shayman, G.O. Till, M. Mahrougui, C.B. Owens, U.S. Ryan, and P.A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. The American Journal of Physiology 263: 51–59. Murphy, H.S., J.A. Shayman, G.O. Till, M. Mahrougui, C.B. Owens, U.S. Ryan, and P.A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. The American Journal of Physiology 263: 51–59.
38.
go back to reference Tran, L.T., K.M. MacLeod, and J.H. McNeill. 2009. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Molecular and Cellular Biochemistry 330: 219–228.PubMedCrossRef Tran, L.T., K.M. MacLeod, and J.H. McNeill. 2009. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Molecular and Cellular Biochemistry 330: 219–228.PubMedCrossRef
Metadata
Title
The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?
Authors
Tuğçe Demirtaş
Tijen Utkan
Ayşe Karson
Yusufhan Yazır
Dilek Bayramgürler
Nejat Gacar
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9867-4

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue